Skip to main
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. reported a year-over-year increase of 1.6% in its product and service revenues, indicating stronger than forecasted growth in the quarter driven by timely deal closures. The expansion of the Premium Large Format (PLF) concept among exhibitors and a solid film slate are anticipated to support long-term growth, with nearly half of total licensing revenues now derived from these efforts. Additionally, the continued adoption of Dolby’s Atmos, Vision, and Imaging Patents positions the company for a notable increase in per-unit royalties as volume demand recovers, while new SaaS-like models tied to patent licensing and the OptiView solution further aim to drive revenue growth.

Bears say

Dolby Laboratories Inc. is projected to experience a year-over-year decline in revenue, with a 7.5% drop in licensing revenue and a 5.7% decrease in products and services, compounded by a 5.5% increase in operating expenses. The company anticipates a high-single-digit revenue decline for fiscal 2026, aligning with similarly declining trends from fiscal 2025, indicating persistent challenges in key sectors like PC and consumer electronics. Additionally, gross margins have decreased from 90.8% to 89.8%, reflecting issues in product and service profitability and highlighting the ongoing pressure on the company's financial performance.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $90.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $90.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.